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Synaptobrevins are vesicle-associated proteins implicated in
neurotransmitter release by both biochemical studies and per-
turbation experiments that use botulinum toxins. To test these
models in vivo, we have isolated and characterized the ﬁrst
synaptobrevin mutants in metazoans and show that neuro-
transmission is severely disrupted in mutant animals. Mutants
lacking snb-1 die just after completing embryogenesis. The
dying animals retain some capability for movement, although
they are extremely uncoordinated and incapable of feeding. We
also have isolated and characterized several hypomorphic
snb-1 mutants. Although fully viable, these mutants exhibit a
variety of behavioral abnormalities that are consistent with a
general defect in the efﬁcacy of synaptic transmission. The
viable mutants are resistant to the acetylcholinesterase inhibitor
aldicarb, indicating that cholinergic transmission is impaired.
Extracellular recordings from pharyngeal muscle also demon-
strate severe defects in synaptic transmission in the mutants.
The molecular lesions in the hypomorphic alleles reside on the
hydrophobic face of a proposed amphipathic–helical region
implicated biochemically in interacting with the t-SNAREs syn-
taxin and SNAP-25. Finally, we demonstrate that double mu-
tants lacking both the v-SNAREs synaptotagmin and snb-1 are
phenotypically similar to snb-1 mutants and less severe than
syntaxin mutants. Our work demonstrates that synaptobrevin is
essential for viability and is required for functional synaptic
transmission. However, our analysis also suggests that trans-
mitter release is not completely eliminated by removal of either
one or both v-SNAREs.
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Synaptic transmission is a calcium-regulated secretory process
that shares many similarities with other secretory mechanisms in
eukaryotic cells. A growing number of molecular components of
the synaptic machinery have been identiﬁed via both biochemical
and genetic approaches (for review, see Bennett and Scheller,
1994; Sudhof, 1995). One class of molecules that participate in the
fusion event is the SNAP receptors (SNAREs; Sollner et al.,
1993a). Distinct, but homologous, members of the v- and
t-SNARE families are thought to mediate trafﬁcking events in
different cellular compartments (for review, see Ferro-Novick and
Jahn, 1994). In neurons the v-SNAREs synaptobrevin (also called
VAMP) and synaptotagmin are found speciﬁcally associated with
synaptic vesicles (Trimble et al., 1988; Perin et al., 1990), and the
t-SNAREs syntaxin and SNAP-25 are localized primarily on the
plasma membrane (Bennett et al., 1992; Garcia et al., 1995).
Stable synaptobrevin/syntaxin/SNAP-25 biochemical complexes
can be assembled and disassembled in vitro (Sollner et al., 1993b),
and these biochemical reactions are proposed to mediate vesicu-
lar fusion.
Synaptobrevin was ﬁrst identiﬁed as a protein associated with
synaptic vesicles isolated from electric organs of the ray (Trimble
et al., 1988). Subsequently, homologs have been isolated from a
variety of organisms, including yeast, Drosophila, and human
(Sudhof et al., 1989; Archer et al., 1990; Gerst et al., 1992;
Protopopov et al., 1993). A variety of evidence suggests that
synaptobrevin family members play an essential role in regulating
fusion events. Saccharomyces cerevisiae snc1 snc2 double mutants
lacking the yeast homologs of synaptobrevin have severe secre-
tory defects (Gerst et al., 1992; Protopopov et al., 1993). Studies
using several botulinum neurotoxins directly implicate synapto-
brevin in the regulation of synaptic transmission (for review, see
Tonello et al., 1996). These potent inhibitors of synaptic trans-
mission are metalloproteases that cleave SNAREs. Tetanus toxin
(TeTx) and several clostridial toxins cleave synaptobrevin at
unique sites (Schiavo et al., 1992, 1993, 1994). In fact, expression
of these toxins in neurons blocks synaptic transmission in vivo
(Sweeney et al., 1995). Furthermore, in b-islet cell lines, the
TeTx-block in Ca
21-induced release of insulin can be overcome
by introducing TeTx-resistant forms of synaptobrevin (Regazziet
al., 1997). However, these toxins also cleave other cellular ho-
mologs of synaptobrevin, such as cellubrevin, which are expressed
in all cells (McMahon et al., 1993). Indeed, tetanus toxin can
inhibit cell membrane repair in ﬁbroblasts and Xenopus oocytes,
suggesting that synaptobrevin-like molecules regulate other fusion
events (Steinhardt et al., 1994). Thus, although TeTx toxin action
suggests a requirement for synaptobrevin in synaptic release, the
possibility remains that protease cleavage of other targets contrib-
utes to the transmission abnormalities in toxin-treated cells.
To examine the role of synaptobrevin in regulating synaptic
transmission, we isolated and characterized Caenorhabditis el-
egans synaptobrevin mutants. SNB-1 was expressed in neurons
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lacking synaptobrevin function died shortly after completing em-
bryogenesis. Viable hypomorphic mutants exhibited a variety of
behavioral, pharmacological, and physiological defects, indicating
that functional synaptobrevin is required for normal synaptic
transmission. Characterization of the molecular lesions in the
hypomorphic mutants implicates a proposed amphipathic–helical
region of SNB-1 in synaptobrevin function.
MATERIALS AND METHODS
Growth and culture of C. elegans. C. elegans was grown at 22.5°C on solid
medium, as described by Sulston and Hodgkin (1988). All mapping,
complementation, and deﬁciency testing was performed by standard
genetic methods (Herman and Horvitz, 1980). Aldicarb, 2-methyl-2-
[methylthio]proprionaldehyde O-[methylcarbamoyl]oxime, was obtained
from Chem Services (West Chester, PA) and was prepared as a 100 mM
stock solution in 70% ethanol. Aldicarb was added to the agar growth
medium after autoclaving.
DNA and RNA manipulations. C. elegans genomic DNA was isolated as
described by (Sulston and Hodgkin, 1988). cDNA was made by reverse-
transcribing RNA, using random hexanucleotide primers as described by
Sambrook et al. (1989). Poly(A
1)-selected RNA was isolated from a
mixed-stage culture of the wild-type strain N2 as previously described
(Nonet and Meyer, 1991). Manipulations of DNA and RNA, including
electrophoresis, blotting, and probing of blots, were performed with
standard procedures except where noted (Sambrook et al., 1989).
Cloning of C. elegans synaptobrevin gene. Degenerate oligonucleotides
SB-1 (59 TNCARCARACNCARGC 39) and SB-2 (59 CCNARNAT-
DATCATCAT 39), corresponding to regions conserved among the bo-
vine, Torpedo, and Drosophila synaptobrevin proteins (Trimble et al.,
1988; Sudhof et al., 1989), were used to amplify the C. elegans gene
speciﬁcally. PCR reactions were performed as described by Innis et al.
(1990). SB-1/SB-2 products were gel-puriﬁed, cloned into pBluescript
KS(
2), and sequenced. Insert DNA was used to screen a lZAP cDNA
library (Lichtsteiner and Tjian, 1993). The inserts of two cDNA clones
isolated were excised from lZAP in vivo to create pSB100 and pSB101.
pSB101 cDNA represents the full-length transcript because it contains a
partial SL1 trans-spliced leader sequence and a 39 poly(A
1) sequence
and is of comparable size to the snb-1 message observed on Northern
blots (see Fig. 3). Analysis of the DNA sequence and the deduced amino
acid coding sequence of the gene were performed on a SPARC station
with the Genetics Computer Group program package (Devereux et al.,
1984). The snb-1 cDNA sequences was deposited into GenBank (acces-
sion number AF003281).
Production of antibodies and immunocytochemistry. TheBamHI–BsaBI
fragment of pSB101 was inserted into pRSETB (Invitrogen, San Diego,
CA) to create the plasmid pSB110. The plasmid encodes a fusion protein
containing a six histidine tag and amino acids 13–88 of the C. elegans
SNB-1 protein. The fusion protein was puriﬁed and used to immunize
rabbits as described in Nonet et al. (1993). SNB-1 antiserum was
immunoafﬁnity-puriﬁed by the method described in Pringle et al. (1991).
Afﬁnity-puriﬁed a-SNB-1 serum was used at 1:50 dilution. Immunocyto-
chemistry was performed as previously described in Nonet et al. (1997).
Chromosomal localization of the snb-1 gene. pSB101 insert DNA was
used to probe an ordered grid of yeast artiﬁcial chromosome (YAC)
clones representing most of the C. elegans genome. The snb-1 probe
hybridized to three overlapping YAC clones: Y7E11, Y6G12, and Y44A7
(Coulson et al., 1988). The cosmid T10H9 was shown to contain snb-1 by
Southern analysis (Coulson et al., 1986). A 5.2 kb HindIII fragment from
cosmid T10H9 containing the complete snb-1 gene was cloned in both
orientations into pBluescript KS(
2) to create pSB102 and pSB103. An-
imals homozygous for nDf18, nDf32, and sDf20 deﬁciencies were ana-
lyzed for the presence of snb-1 and xol-1 sequences (Rhind et al., 1995)
by using single-worm PCR (Williams et al., 1992). Deﬁciency animals
were isolated as dead eggs segregating from Df/dpy-11(e224) animals.
sDf20 and nDf32 removed snb-1, but not the control locus (xol-1). The
snb-1::lacZ fusion construct pSB111 was created by inserting a 3.2 kb
HindIII–NaeI fragment of pSB102 into the MscI--HindIII fragment of
pPD21.28 (Fire et al., 1990). Transgenic animals expressing the fusion
construct were examined by using X-gal as a substrate for lacZ.T h e
genomic region was sequenced (GenBank accession number AF 003282).
Isolation of snb-1 mutants. snb-1(md247) was isolated in a genetic
screen for aldicarb-resistant mutants (Miller et al., 1996). Additional
alleles were isolated in three noncomplementation screens. Wild-type
males were mutagenized with ethyl methanesulfonate and crossed to
dpy-11(e224) snb-1(md247) ric-4(md1088); xol-1(y9) ﬂu-2(e1003) in the
ﬁrst screen, to dpy-11(e224) snb-1(md247); xol-1(y9) ﬂu-2(e1003) in the
second screen, and to dpy-11(e224) snb-1(js17); xol-1(y9) ﬂu-2(e1003) in
the last screen. In each case, animals resistant to aldicarb were selected
by placing the cross-progeny on plates containing either 0.5 or 0.75 mM
aldicarb. js17 was isolated from the ﬁrst screen of ;30,000 cross-progeny,
js43 and js44 from the second screen of 50,000 cross-progeny, and js124
from the third screen of 32,000 cross-progeny. The entire coding region
of the snb-1 locus was sequenced from the mutants. js124 i saCt oT
transition at position 1 of codon 50, js17 and js43 result from C to T
transitions at position 1 of codon 62, js44 results fromaCt oTtransition
at position 2 of codon 65, and md247 results from the duplication of the
sequence CGCTATCGTCGTCATTCTTAT (encoding amino acids 92–
99) and its insertion after the ﬁrst base of codon 100. The lesion is a 20
bp duplication separated by a TA sequence and may be the result of a Tc1
transposition event (Mori et al., 1988; Plasterk, 1991). Introduction of the
pSB103 genomic construct by germline transformation (Mello et al.,
1991) rescued the behavioral phenotypes of md247 and js124. snb-1 was
mapped genetically between dpy-11 and unc-68: from dpy-11(e224) unc-
68(r1158)/snb-1(md247) animals, two of seven Dpy non-Unc recombi-
nants carried the snb-1(md247) lesion. snb-1(md247) complements nDf18
and sDf36 but failed to complement nDf32, sDf20, and sDf30.A l lsnb-1
alleles failed to complement nDf32.
Behavioral assays. Locomotion was assayed by imaging L4-staged ani-
mals shortly after they were deposited onto fresh agar plates containing
an E. coli lawn. CCD camera images were collected for 1 min with an
LG3 frame grabber (Scion) at 1 sec intervals at a magniﬁcation between
1.6 and 2.53. Distances traveled were calculated by summing movements
in the position of the tail by using the program Scion Image (Scion).
Defecation was observed under a dissecting microscope, and cycles were
recorded with a simple computer program (Liu and Thomas, 1994).
Pharyngeal pumping of mutant animals with slow pumping rates was
assayed by counting pumping for 1 min intervals. Pharyngeal pumping of
animals with fast rates (.120 pumps/min) was assayed by counting
pumps from digital images captured at 15 frames/sec for 20 sec intervals.
Resistance to aldicarb and levamisole. Mutants were assayed for acute
exposure to aldicarb and levamisole. Aldicarb resistance was examined
by transferring individual animals to plates containing aldicarb and
assaying them for paralysis 4 hr after exposure. Animals were considered
paralyzed if they failed to move even if prodded with a platinum wire.
Levamisole resistance was examined by placing 25 worms in S-basal
medium (Sulston and Hodgkin, 1988) with 100 mM levamisole and
scoring them for movement by examining video images of the animals at
different time points.
Electrophysiology. Electropharyngeograms (EPGs) were recorded with
an AC preampliﬁer (designed by David Brumley, University of Oregon)
and LabView Acquisition software as previously described (Avery et al.,
1995). Bath solution consisted of M9 with 2.5–5 mM serotonin to stimu-
late pumping. Only recordings from young adult hermaphrodites with at
least 10 pharyngeal pumps were used in analysis. Analysis of the records
was performed as described in Iwasaki et al. (1997) except that ampli-
tudes were calculated as peak-to-peak.
RESULTS
Isolation of a synaptobrevin homolog in C. elegans
We isolated partial cDNA clones encoding a C. elegans synapto-
brevin molecule with PCR. A complete cDNA representing the
transcript from the gene was isolated from an embryonic cDNA
library (see Materials and Methods). The deduced transcript is
predicted to encoded a protein product with 68% identity to
human synaptobrevin-2 (Fig. 1). The predicted protein is most
similar to neuronal synaptobrevin molecules from metazoans
(60–68% identity) but also is very similar to the ubiquitously
expressed rat cellubrevin (66% identity) and a Drosophila synap-
tobrevin expressed in gut (59% identity). The gene was named
synaptobrevin (snb-1) because it represents the ﬁrst characterized
member of this family in C. elegans.
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nervous system
To ascertain the expression pattern of the gene in the nematode,
we raised antisera directed against a bacterially expressed SNB-1
fusion protein. An afﬁnity-puriﬁed synaptobrevin antiserum was
incubated with ﬁxed whole adult C. elegans animals, and the
antibodies were detected by FITC-conjugated secondary anti-
sera. SNB-1 was detected in the nervous system. The majority of
synaptobrevin immunoreactivity was restricted to the major pro-
cess bundles of C. elegans. The nerve ring, ventral cord, and dorsal
cord were highly immunoreactive (Fig. 2A–C). Faint ﬂuorescence
also was detected in some neuronal cell bodies. By contrast,
synaptobrevin was not detected in most commissural and den-
dritic processes. Previously characterized C. elegans synaptic ves-
icle proteins RAB-3 (Fig. 2D) and synaptotagmin (data not
shown) colocalized with synaptobrevin (Nonet et al., 1993, 1997).
In addition, synaptobrevin immunoreactivity was mislocalized in
cell bodies in unc-104, as would be expected of a synaptic vesicle-
associated protein (Hall and Hedgecock, 1991; Nonet et al., 1993,
1997). unc-104 encodes a kinesin required for the transport of
synaptic vesicles from the cell body to the synapse (Otsuka et al.,
1991). Thus, C. elegans SNB-1 shows the expected distribution of
a synaptic vesicle-associated protein.
Because it was not feasible to determine whether all neurons
expressed SNB-1 from the examination of immunohistochemical-
stained samples, the expression pattern of the gene was examined
by using a translational lacZ fusion (see Materials and Methods).
Consistent with our immunohistochemistry data, SNB-1 was ex-
pressed in the vast majority of all neurons in the nerve ring ganglia
(Fig. 2G) and the ventral cord (Fig. 2H). Moreover, the expression
of snb-1 assayed by lacZ was restricted to neuronal tissue, although
expression also has been observed in the spermatheca with green
ﬂuorescent protein (GFP) fusions (data not shown). We conclude
that snb-1 encodes a neuronal synaptobrevin.
Isolation of synaptobrevin mutants
As a ﬁrst step toward isolating mutations in snb-1, the gene was
positioned on the physical map of C. elegans (Fig. 3; see Materials
and Methods). The gene mapped to YAC clones containing DNA
from the center of chromosome V. The genetic position was
reﬁned further by determining whether snb-1 was removed by a
variety of deﬁciencies of the region (Fig. 3A). The mapping data
positioned the gene in the 0.3 map unit interval between the
dpy-11 and unc-68 loci. A genomic clone containing the entire
coding region was isolated from a cosmid clone (Fig. 3B; Coulson
et al., 1986), and the single intron of the gene was identiﬁed by
sequencing of the genomic region (Fig. 3C).
A variety of mutants encoding C. elegans synaptic components
share a common attribute; they are resistant to the acetylcholines-
terase inhibitor aldicarb (Nonet et al., 1993, 1997; Nguyen et al.,
1995; Miller et al., 1996; Iwasaki et al., 1997). The mutation
ric(md247) was isolated in a selection for aldicarb-resistant mu-
tants (Miller et al., 1996), and genetic mapping placed md247
close to the physical position of snb-1. md247 was demonstrated to
be a lesion in the snb-1 gene by two criteria. First, md247 mutants
transformed with a genomic clone of the synaptobrevin gene are
rescued to wild type, as assayed by both behavioral and aldicarb
resistance assays. Second, sequencing of the snb-1 coding region
identiﬁed a mutation in md247 that could account for the gene
defect.
Additional snb-1 mutations were isolated in noncomplementa-
tion screens. Wild-type males were mutagenized and crossed to
marked snb-1 strains (see Materials and Methods). Cross-progeny
were screened for behavioral defects, or aldicarb resistance was
used to identify new snb-1 mutations. Four independent muta-
tions, js17, js43, js44, and js124, were isolated in the three genetic
screens. js17, js43, and js44 are all similar to snb-1(md247) in that
homozygous mutant animals are viable and also viable in trans to
a deﬁciency of the region. By contrast, the js124 mutation is
homozygous lethal. These animals arrest development just after
completing embryogenesis and hatching, and they tend to adopt a
coiled position similar to that observed in lethal cha-1 choline
acetyltransferase mutants (Rand, 1989). Animals heterozygous
for js124 were not resistant to aldicarb and showed no behavioral
abnormalities, indicating that the lesion had no dominant or
gain-of-function characteristics. In addition, js124 in trans to a
deﬁciency of the region phenotypically resembled the js124 ho-
mozygotes. Finally, the lethal phenotype of js124 was rescued to
wild type by the introduction of a wild-type snb-1 genomic clone,
thus conﬁrming that this phenotype is solely the result of the
lesion in the snb-1 locus.
Sequencing of the alleles revealed that the md247 lesion dupli-
cates 20 bp and results in a shift in the reading frame at amino acid
100, midway in the transmembrane domain of SNB-1 (Fig. 4). js17
and js43 are independently isolated missense mutations resulting in
an L62F substitution, whereas js44 consists of a missense change
resulting in an A66G substitution (Fig. 4). None of the mutants,
Figure 1. Similarity among synaptobrevin molecules. Alignment of synaptobrevin family proteins from C. elegans (SNB-1 worm), Drosophila (n-syb ﬂy;
DiAntonio et al., 1993), rat (cellubrevin; McMahon et al., 1993) human (SYB1 and SYB2; Archer et al., 1990), and S. cerevisiae (SNC1 yeast; Gerst et al.,
1992). The standard single letter amino acid code is used. Dots represent identity with the C. elegans sequence. Amino acid numbering appears at the
right.
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ities (Fig. 2E) (data not shown). js124 results in a Q50.STOP
nonsense lesion (Fig. 4); hence the js124 phenotype likely repre-
sents the snb-1 null phenotype.
Phenotypes of synaptobrevin mutants
The snb-1 mutants all exhibit a variety of behavioral abnormali-
ties. The viable mutants all remain capable of coordinated move-
ment. However, their movements are easily differentiated from
the wild type (Table 1). The animals are lethargic and have a
tendency to jerk, especially during backward motion. Synaptobre-
vin null js124 animals arrested as L1 larvae and often adopted a
coiled position. These animals also remained capable of making
some movements. To characterize the movements, we examined
the animals via video microscopy. Time-lapse imaging (Fig. 5)
demonstrated that these animals were capable of making semi-
coordinated movements (Fig. 5). Additionally, pharyngeal pump-
ing, which mediates feeding behavior, was depressed in all of the
mutants (Table 1). Furthermore, the defecation cycle time was
longer, and enteric muscle contraction step of the defecation cycle
(Avery and Thomas, 1997) failed more frequently than in the wild
type (Table 1). These behavioral defects presumably all represent
manifestations of the underlying impairment of synaptic trans-
Figure 2. Expression of snb-1 in the C. elegans nervous system. A–F, Whole worms ﬁxed and stained with a-SNB-1, a-RAB-3, and a-UNC-64 (syntaxin)
primary antibodies and visualized with FITC- or Cy3-conjugated antibodies. A, Lateral view of the head region of a wild-type adult hermaphrodite
showing SNB-1 immunoreactivity in the nerve ring, pharyngeal nervous system, and ventral and dorsal nerve cords. B, Ventral view of the tail region
of a wild-type adult hermaphrodite showing SNB-1 immunoreactivity in the ventral nerve cord. C, D, Ventral view of the midsection of a wild-type adult
hermaphrodite showing colocalization of SNB-1 (C) and RAB-3 (D) immunoreactivity in the ventral nerve cord. E, Ventral view of the head of SNB-1
immunoreactivity in an adult snb-1(md247) mutant. The SNB-1 mutant protein remains limited to the synaptic regions of the SAB neurons. F, Similar
view of UNC-64 syntaxin immunoreactivity in a wild-type animal reveals all processes in the head. G, H, Transgenic jsEx96 animals expressing the
psnb-1::lacZ reporter construct pSB111 stained for b-galactosidase activity, using X-gal. lacZ contains an SV40 nuclear localization signal. G, Lateral view
of the head region of an adult hermaphrodite showing staining neurons in the head ganglia and pharynx. H, Lateral view of the vulval region of an adult
hermaphrodite showing staining in the motor neurons in the ventral cord and two neurons in the deirid sensillum.
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much less vigorous than those of the wild type, are evidence that
some neuromuscular transmission persists in the absence of
synaptobrevin.
Synaptic transmission defects in
synaptobrevin mutants
To assess neurotransmission in snb-1 mutants, we examined their
response to pharmacological agents. We quantiﬁed the resistance
of snb-1 mutants to the acetylcholinesterase inhibitor aldicarb
(Fig. 6). All three viable alleles were resistant to aldicarb, as was
the acetylcholine receptor mutant unc-29 (Fleming et al., 1997)
The aldicarb resistance suggests that cholinergic transmission is
impaired in the mutants. We also examined the response of snb-1
mutants to the acetylcholine receptor agonist levamisole (Lewis
et al., 1980a,b). snb-1 mutants and wild-type animals showed
comparable sensitivity to the drug (Fig. 6). By contrast, the
acetylcholine receptor mutant unc-29 was extremely resistant to
the drug. Thus, the assay indicates that postsynaptic responses are
fundamentally intact, suggesting that cholinergic transmission is
impaired presynaptically in snb-1 mutants.
We also examined electrical activity in the pharynx, using an
extracellular recording method devised by Raizen and Avery
Figure 3. The snb-1 locus. A, Genetic
map of the snb-1 region of chromosome
V showing three deﬁciencies used to
position the locus. B, Physical map of
the snb-1 region showing cosmid and
yeast artiﬁcial chromosome clones. The
position of the unc-68 gene is shown
also. C, Restriction map of the genomic
snb-1 gene. Below the restriction map a
schematic diagram shows the intron–
exon structure of the snb-1 gene and
the sequences contained in plasmid
constructs used in this study. The
pSB103 insert is identical to the
pSB102 insert shown. E, EcoRI; X,
XbaI; N, NaeI; H, HindIII restriction
endonuclease sites. D, Autoradiograph
of a Northern blot probed with a snb-1
cDNA fragment. Poly(A
1) RNA (10
mg) isolated from a culture of mixed-
stage hermaphrodites was loaded on
the gel. Size standards, labeled in kilo-
bases, are on the right.
Figure 4. Molecular lesions in snb-1 mutants. The carboxyl sequences of four synaptobrevin sequences are shown aligned. The standard single letter
amino acid code is used. The hydrophobic transmembrane region of the proteins is indicated. Sequences forming an a-helical structure form a repeating
seven-amino-acid unit. The amino acids of the helix are labeled a through g. a and d above the sequence alignment represent the amino acids on the
hydrophobic face of a predicted amphipathic–helix structure that could be formed by the proteins. The lesions found in the four snb-1 mutations are
labeled in bold. The molecular lesions are detailed in Materials and Methods.
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pharyngeal muscle as well as for those resulting from synaptic
input. We examined inhibitory currents elicited by the glutama-
tergic motor neuron M3, which shortens the length of the con-
traction of pharyngeal muscle (Avery, 1993). Wild-type animals
exhibited three to ﬁve distinct M3-induced transients during each
pharyngeal pump (Fig. 7A, Table 2). By contrast, M3 transients
were usually completely absent or extremely small in recordings
from snb-1(md247) mutants (Fig. 7B, Table 2). M3 transients of
reduced amplitude also were observed in records of both js17 and
js44 animals (Fig. 7C,D, Table 2). Consistent with a reduction in
M3 activity, pharyngeal pump duration was increased in all of the
mutants (Table 2). The activity of MC neurons, a pair of motor
neurons that stimulate pharyngeal contractions (Raizen et al.,
1995), also was altered in snb-1 mutants. Speciﬁcally, we noted an
increase in MC transients among pumps that failed to elicit
pharyngeal contractions (Fig. 7B–D). These subthreshold MC
failures were observed rarely in wild-type animals (data not
shown) (Iwasaki et al., 1997). In summary, our pharmacological
and physiological assays demonstrate that both cholinergic and
glutamatergic transmission are impaired in snb-1 hypomorphic
mutants.
v-SNARE double mutants remain capable of movement
Biochemical analysis that led to the SNARE hypothesis identiﬁed
both synaptobrevin (Sollner et al., 1993a,b) and synaptotagmin
(Schiavo et al., 1995) as v-SNARES of synaptic vesicles. To assess
whether the residual behaviorally assessed neurotransmission was
a consequence of synaptotagmin function, we constructed snt-
1(md290); snb-1 (js124)/dpy-11(e224) animals and examined
snt-1; snb-1 double mutants segregating from the parents. The
double mutants were phenotypically very similar to snb-1(js124)
animals. They were capable of some movement (Fig. 8) and
arrested development in the ﬁrst larval stage. By contrast, mu-
tants lacking the t-SNARE unc-64 syntaxin were virtually com-
pletely paralyzed (Fig. 8). Behaviorally, the snb-1 and snt-1; snb-1
double mutants were distinguishable because pharyngeal
pumping was reduced in the double mutant (snb-1, 11.7 6 7.2
pumps/min; snt-1; snb-1, 0.5 6 0.8 pumps/min; unc-64 0.15 6
0.3 pumps/min). However, in contrast to unc-64 syntaxin mu-
Table 1. Behavioral defects of synaptobrevin mutants
Strain
Locomotion
a
Pharyngeal pumps/min
c
Defecation
d
Speed (mm/sec) Efﬁciency
b Cycle time (sec) EMCs (%)
e
N2 160 6 36 0.63 250 6 30 42.0 6 3.3 98
md247 89 6 20 0.43 64 6 20 66.1 6 11.1 85
js17 44 6 11 0.26 206 6 24 47.2 6 3.9 62
js44 73 6 33 0.32 N.D. 51.5 6 5.5 83
All errors are listed as SD from the mean.
a Data shown represent the mean of at least 19 animals. This methods underestimates the distance traveled in fast-moving animals because of the sinusoidal locomotion pattern
of worms.
b Efﬁciency is deﬁned as displacement/total distance traveled. snb-1 mutants have a tendency to alternate short periods of forward and backward motion.
c Data Shown represent the mean of at least 15 young animals for each genotype.
d Data shown represent observations of the defecation cycles of at least 10 animals (over 100 defecation cycles in total.)
e The percentage of defecation cycles with an enteric muscle contraction (see Avery and Thomas, 1997).
Figure 5. Locomotion of snb-1 mutants. Shown are bright-ﬁeld images of wild-type and snb-1(js124) L1 larvae on an E. coli lawn at indicated time
intervals (top right, in seconds). Scale bar, 100 mm.
Figure 6. Pharmacological properties of
snb-1 mutants. A, Aldicarb sensitivities of
snb-1 mutants and the wild type. Shown is
the percentage of animals paralyzed after
a 4 hr exposure to various concentrations
of aldicarb on plates seeded with E. coli:
wild type (F), js17 (M), js44 (), md247
(E), and unc-29 (L). B, Levamisole sensi-
tivities of snb-1 mutants and the wild type.
Shown is the percentage of animals para-
lyzed after exposure of adult animals to
100 mM levamisole for various times: wild
type (F), js17 (M), js44 (), md247 (E),
and unc-29 (L).
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Horvitz, 1990), pumping of the double mutant could still be
markedly stimulated by the addition of exogenous serotonin
(snt-1; snb-1 1 5HT, 12.1 6 7.1; unc-64 1 5HT, 0.05 6 0.15).
In summary, mutants lacking both snb-1 and snt-1; snb-1 closely
resemble the snb-1 mutant at a behavioral level; they remain
capable of some neuromuscular signaling.
DISCUSSION
We have isolated and characterized a gene encoding a C. elegans
synaptobrevin that functions in the synaptic release pathway.
SNB-1 is extremely likely the homolog of the synaptic vesicle-
associated synaptobrevin-1 and -2 molecules expressed in the
vertebrate nervous system. snb-1 is expressed in the nervous
system, and SNB-1 protein colocalizes with C. elegans RAB-3 and
synaptotagmin, suggesting that the protein is synaptic vesicle-
associated. Furthermore, snb-1 mutants have synaptic transmis-
sion deﬁcits, indicating that the molecule functions in neuronal
exocytosis in C. elegans.
snb-1 joins a long list of C. elegans mutants that are resistant to
the drug aldicarb (Rand and Nonet, 1997). These mutants include
genes encoding products involved in acetylcholine synthesis and
vesicular loading (Alfonso et al., 1993, 1994), regulation of vesicle
trafﬁcking and fusion (Maruyama and Brenner, 1991; Gengyo-
Ando et al., 1993; Nonet et al., 1993, 1997), and acetylcholine
Figure 7. Pharyngeal recordings
from wild-type and snb-1 mutants.
Shown are characteristic recordings
of the wild-type strain N2 (A), snb-
1(md247) (B), snb-1(js17) (C), and
snb-1(js44) (D). Arrows indicate MC-
induced transients, and the ﬁlled cir-
cles indicate M3-induced transients.
All traces are millivolts versus time.
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Lewis et al., 1980a; Fleming et al., 1997). Thus, the drug resis-
tance of the hypomorphic mutants suggests that synaptic trans-
mission is impaired in snb-1 mutants. The pleiotropic behavioral
abnormalities provide additional evidence for synaptic deﬁcien-
cies. Finally, the electrophysiological abnormalities in M3 trans-
mission in snb-1 mutants also support a requirement for synap-
tobrevin for synaptic transmission. Unfortunately, our simple
physiological assay cannot be applied to ﬁrst-larval-stage animals.
Thus, we have not conﬁrmed that M3 activity is absent in our
lethal snb-1 mutant. However, M3 activity is often absent even in
the viable snb-1(md247) mutants.
Our analysis of snb-1 mutants clearly demonstrates that synap-
tobrevin is essential for viability of C. elegans. Animals lacking
snb-1 are able to complete embryogenesis but arrest development
shortly after hatching and die several days later. This lethality is
rescued by introduction of a transgene carrying wild-type snb-1
sequences. The mutant animals are extremely uncoordinated and
rarely move far from where they hatch. However, the animals are
capable of some movements, including head foraging movements.
This arrest phenotype is very similar to the phenotype of mutants
lacking the cha-1 choline acetyltransferase protein (Rand, 1989),
the unc-17 vesicular ACh transporter (Alfonso et al., 1993), and
the unc-104 synaptic vesicle kinesin motor protein (Hall and
Hedgecock, 1991). However, the phenotype contrasts with that of
mutants lacking syntaxin (unc-64), which are paralyzed on hatch-
ing (O. Saifee, L. Wei, and M. Nonet, unpublished data). Thus
complete disruption of the v-SNARE synaptobrevin and corre-
sponding t-SNARE syntaxin result in different defects in synaptic
transmission.
Our analysis of the behavioral phenotypes of the snb-1 null
mutant suggests that transmitter release is not abolished com-
pletely in the absence of synaptobrevin. First, snb-1 animals are
still capable of some rudimentary movements. In fact, snb-
1(js124) animals move better in the presence of aldicarb (data not
shown), indicating that some ACh release is occurring at neuro-
muscular junctions in the absence of SNB-1. Additionally, pha-
ryngeal pumping (10–20 pumps/min) is observed in snb-1 null
mutants. By contrast, pharyngeal pumping is essentially absent in
both syntaxin null mutants (0.15 pumps/min) (O. Saifee, L. Wei,
and M. Nonet, unpublished data) and cha-1 choline acetyltrans-
ferase null mutants (,1 pump/min) (Avery and Horvitz, 1990). In
Drosophila, expression of synaptobrevin-speciﬁc protease tetanus
toxin in neurons blocks evoked release at the neuromuscular
junction but does not eliminate spontaneous miniature release
events (Broadie et al., 1995). It is possible that the movement and
pumping in C. elegans snb-1 mutants are mediated by spontaneous
fusion events that do not require snb-1. A more likely possibility
is that the residual release events use another synaptobrevin-like
molecule expressed in the nervous system. For example, both
cellubrevin and synaptobrevin-2 can contribute to exocytosis of
insulin from pancreatic b-cells (Regazzi et al., 1997). A number
of other synaptobrevin-related molecules apparently are ex-
pressed in C. elegans, because the Genome Sequencing Project
has identiﬁed at least ﬁve genes with similarity to synaptobrevin.
The most conserved of these sequences, F23H12.1, shares 47%
identity with snb-1. However, this gene appears to be expressed
primarily in the gut (L. Wei and M. Nonet, unpublished results).
Despite this residual movement, which probably represents resid-
ual transmitter release, synaptobrevin is essential for the viability
of C. elegans.
The ﬁnding of Broadie et al. (1995) that synaptic vesicles
remained docked in Drosophila neurons expressing tetanus toxin
and our ﬁnding that C. elegans snb-1 null mutants remain capable
of movement both suggest that synaptobrevin is not essential for
the docking of synaptic vesicles before release. An alternative
interpretation is that synaptobrevin and synaptotagmin both par-
ticipate in docking and that docking requires only one of the two
molecules. Schiavo et al. (1997) provided biochemical support of
such a hypothesis by demonstrating a physical interaction be-
tween synaptotagmin and SNAP-25 that could account for dock-
ing in the absence of synaptobrevin. The difference in the phe-
notype of C. elegans mutants lacking unc-64 syntaxin and double
mutants lacking both synaptobrevin and synaptotagmin suggests
that more release of transmitter occurs in the absence of both
v-SNAREs than in the absence of the t-SNARE syntaxin. A likely
explanation for this is that docking is still occurring in absence of
the v-SNAREs. Because, in the absence of synaptobrevin in
Drosophila, vesicle docking occurs at the ultrastructural level
(Broadie et al., 1995), presumably one of the remaining vesicle
proteins is involved in the docking of vesicles. rab-3 would seem
to be an ideal candidate because C. elegans mutants lacking rab-3
result in a more diffuse distribution of vesicles around the syn-
aptic release site, a phenotype that can be explained by a reduc-
tion in the efﬁciency of docking (Nonet et al., 1997). A combina-
tion of behavioral and morphological analyses of these and other
double mutant and triple mutant combinations may help in the
identiﬁcation of these other required proteins.
The hypomorphic lesions we characterized provide some in-
sight into the function of synaptobrevin. The md247 mutation is
the most unusual lesion we characterized. This lesion shifts the
reading frame of SNB-1 half-way through the transmembrane
domain, leaving only 13 amino acids of the native transmembrane
domain to act as a membrane anchor (see Fig. 4). Because the
mutant SNB-1 protein remains speciﬁcally localized to synaptic
regions in md247 animals (see Fig. 2), the mutant protein is
probably still associated with vesicles. Consistent with this hy-
pothesis, Whitley et al. (1996) have demonstrated that 12 hydro-
phobic residues are sufﬁcient to anchor synaptobrevin into micro-
somal membranes. Synaptobrevin probably does not remain
associated with the vesicle via interactions with other proteins,
because deletion of the transmembrane domain of a GFP-tagged
SNB-1 results in a ubiquitous distribution of this fusion protein in
neurons (M. Nonet, unpublished results). Presently, we are char-
acterizing the transmembrane sequences required for snb-1 func-
tion by site-directed mutagenesis of this domain.
SNARE complex formation is proposed to be mediated by the
assembly of a coiled-coil structure composed of hypothetical
amphipathic–helical domains within the syntaxin, synaptobrevin,
Table 2. Summary of physiological defects in snb-1 mutants
Strain Pump duration
a(msec) M3s/pump
b M3 amplitude
c
Wild type 134 6 2 4.04 6 0.08 0.354 6 0.005
md247 320 6 5 0.65 6 0.10 0.169 6 0.004
js17 286 6 6 2.20 6 0.15 0.173 6 0.003
js44 163 6 4 2.47 6 0.12 0.209 6 0.004
Errors are displayed as SEM.
a Pump duration was deﬁned as the time from the peak of the E-phase transient to
the peak of the R-phase transient (Raizen and Avery, 1994).
b M3 transients were identiﬁed with an algorithm as described in Iwasaki et
al.(1997).
c M3 amplitudes are normalized to the amplitude of the R-phase transient.
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1994). The lesions in the hypomorphic js17 and js44 alleles lie on
the hydrophobic faces of the proposed amphipathic–helix region
of synaptobrevin that could mediate formation of a coiled-coil
structure. Because protein levels are not altered dramatically in
these mutants, the lesions probably do not affect snb-1 function
simply by altering the stability of the protein. Rather, they prob-
ably affect the interactions of synaptobrevin with the t-SNAREs
or with other molecules. Further supporting this interpretation,
these snb-1 lesions exhibit allele-speciﬁc synergism with lesions in
the amphipathic–helix domain of syntaxin (O. Saifee, L. Wei,
and M. Nonet, unpublished data). Although synaptobrevin
binds to syntaxin and SNAP-25, only a few speciﬁc amino acids
of the protein have been implicated directly in SNARE com-
plex formation. Hao et al. (1997) recently have examined the
ability of point mutations and small deletions of synaptobrevin
to form functional complexes with syntaxin and SNAP-25.
Although deletions of most of the protein blocked interactions
with syntaxin in an in vitro binding assay, a deletion of the
region (corresponding to amino acids 63–73 in SNB-1) encom-
passing the js44 lesion increased the afﬁnity of synaptobrevin
for syntaxin. However, in a yeast two-hybrid assay the same
deletion failed to interact with syntaxin (Hao et al., 1997). The
different behavior of lesions in this region in vitro and in vivo
illustrates the need to correlate in vivo function and in vitro
biochemistry to dissect the role of synaptobrevin in vesicle
fusion efﬁciently. Our mutants provide the ﬁrst in vivo evi-
dence that the helical domain is important for synaptobrevin
function.
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